AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, exp...
Will the company address any recent inventory, cash‑flow, or profitability concerns that have affected the share price?
How might analyst coverage and sentiment change after the conference, and what impact could that have on the stock?
Is there potential for new partnership or reimbursement announcements that could drive revenue growth?
22 days ago